{"transactions":[{"id":2033209,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-03T21:39:14.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":415000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2024, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":415000,"derivative":{"exercise_price":7.97,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":415000},"source":{"system":"sec-edgar","filing":"0001209191-23-006910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123006910/doc4.xml","form_type":"4"}},{"id":2078863,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-21T22:00:16.000Z","date":"2022-12-20","kind":"purchase","acquired":true,"shares":6300,"price":8.375,"value":52762.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $8.32 to $8.44, inclusive.  The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth herein."}],"balance_after":132619,"source":{"system":"sec-edgar","filing":"0001209191-22-062349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122062349/doc4.xml","form_type":"4"}},{"id":2078862,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-21T22:00:16.000Z","date":"2022-12-19","kind":"purchase","acquired":true,"shares":1150,"price":8.47,"value":9740.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,250 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (\"ESPP\") on November 15, 2021 and 1,220 shares acquired under the ESPP on May 13, 2022."}],"balance_after":126319,"source":{"system":"sec-edgar","filing":"0001209191-22-062349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122062349/doc4.xml","form_type":"4"}},{"id":2416944,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T00:50:01.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2023, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":475000,"derivative":{"exercise_price":12.77,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001209191-22-006577","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122006577/doc4.xml","form_type":"4"}},{"id":3138310,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-05-22T22:13:15.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":72296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":72296,"derivative":{"exercise_price":3.2,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":72296},"source":{"system":"sec-edgar","filing":"0001493152-20-009762","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220009762/ownership.xml","form_type":"4"}},{"id":3138309,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-05-22T22:13:15.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on March 31, 2021, and in three equal annual installments thereafter."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001493152-20-009762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220009762/ownership.xml","form_type":"4"}},{"id":3203726,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-18T20:34:18.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":127704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Contingent upon stockholder approval of an amendment to the 2015 Equity Incentive Plan (the \"2015 Plan\") at the Annual Meeting of Stockholders scheduled for May 20, 2020 to increase the number of shares available under the 2015 Plan, Mr. Siffert will also be entitled to an additional grant of 72,296 stock options and a grant of 100,000 shares of restricted stock as soon as practicable after the amendment of the 2015 Plan. The stock options contingent upon stockholder approval will have an exercise price determined at the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":127704,"derivative":{"exercise_price":1.45,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":127704},"source":{"system":"sec-edgar","filing":"0001493152-20-004252","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220004252/ownership.xml","form_type":"4"}},{"id":3553083,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-18T21:58:22.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest 25% on February 11, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":110000,"derivative":{"exercise_price":6.7,"expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001144204-19-020317","document":"tv519202_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419020317/tv519202_4.xml","form_type":"4"}},{"id":3553082,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-18T21:58:22.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest 25% on January 31, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":60000,"derivative":{"exercise_price":6.59,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001144204-19-020317","document":"tv519202_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419020317/tv519202_4.xml","form_type":"4"}},{"id":3558039,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-11T22:54:38.000Z","date":"2019-04-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":7.24,"expiration_date":"2029-04-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001144204-19-019351","document":"tv518744_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419019351/tv518744_4.xml","form_type":"4"}},{"id":3933003,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-15T12:40:29.000Z","date":"2018-05-15","kind":"disposition_to_issuer","acquired":false,"shares":2905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2018, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Novartis AG, a company organized under the laws of Switzerland (\"Parent\"), and Novartis AM Merger Corporation, a Delaware corporation and an indirect wholly-owned subsidiary of the Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $218.00 per share (the \"Offer Price\") in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding stock option was canceled in exchange for a lump sum cash payment equal the excess of (A) the Offer Price minus (B) the Exercise Price, multiplied by the number of shares of Common Stock underlying the option."}],"balance_after":0,"derivative":{"exercise_price":133.8,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":2905},"source":{"system":"sec-edgar","filing":"0001209191-18-030130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919118030130/doc4.xml","form_type":"4"}},{"id":3933002,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-15T12:40:29.000Z","date":"2018-05-15","kind":"disposition_to_issuer","acquired":false,"shares":7755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2018, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Novartis AG, a company organized under the laws of Switzerland (\"Parent\"), and Novartis AM Merger Corporation, a Delaware corporation and an indirect wholly-owned subsidiary of the Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $218.00 per share (the \"Offer Price\") in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding stock option was canceled in exchange for a lump sum cash payment equal the excess of (A) the Offer Price minus (B) the Exercise Price, multiplied by the number of shares of Common Stock underlying the option."}],"balance_after":0,"derivative":{"exercise_price":69.25,"expiration_date":"2027-05-30","underlying":"Common Stock","underlying_shares":7755},"source":{"system":"sec-edgar","filing":"0001209191-18-030130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919118030130/doc4.xml","form_type":"4"}},{"id":3933001,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-15T12:40:29.000Z","date":"2018-05-15","kind":"disposition_to_issuer","acquired":false,"shares":1106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2018, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Novartis AG, a company organized under the laws of Switzerland (\"Parent\"), and Novartis AM Merger Corporation, a Delaware corporation and an indirect wholly-owned subsidiary of the Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $218.00 per share (the \"Offer Price\") in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 1,106 shares underlying Restricted Stock Units (the \"RSUs\"). Pursuant to the Merger Agreement, each outstanding RSU was canceled in exchange for a lump sum cash payment equal to (i) the Offer Price multiplied by (ii) the number of shares of Common Stock underlying the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 6, 2018, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Novartis AG, a company organized under the laws of Switzerland (\"Parent\"), and Novartis AM Merger Corporation, a Delaware corporation and an indirect wholly-owned subsidiary of the Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $218.00 per share (the \"Offer Price\") in cash."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-030130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919118030130/doc4.xml","form_type":"4"}},{"id":3978780,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-30T17:55:33.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":2905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable on March 13, 2019, subject to the Reporting Person's continuous service with the Issuer on such date."}],"balance_after":2905,"derivative":{"exercise_price":133.8,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":2905},"source":{"system":"sec-edgar","filing":"0001209191-18-022244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919118022244/doc4.xml","form_type":"4"}},{"id":3978779,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-30T17:55:33.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":1106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares underlying this restricted stock award will vest on March 13, 2019, subject to the Reporting Person's continuous service with the Issuer on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares underlying this restricted stock award will vest on March 13, 2019, subject to the Reporting Person's continuous service with the Issuer on such date."}],"balance_after":1106,"source":{"system":"sec-edgar","filing":"0001209191-18-022244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919118022244/doc4.xml","form_type":"4"}},{"id":4298188,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-01T19:40:20.000Z","date":"2017-05-30","kind":"grant","acquired":true,"shares":5301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable with respect to one-third of the shares on May 30, 2018; the remaining shares shall vest and become exercisable in twenty-four equal monthly installments thereafter, subject to the Reporting Person's Continuous Service, as that term is defined in the Plan through each such date."}],"balance_after":5301,"derivative":{"exercise_price":69.25,"expiration_date":"2027-05-30","underlying":"Common Stock","underlying_shares":5301},"source":{"system":"sec-edgar","filing":"0001209191-17-036959","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919117036959/doc4.xml","form_type":"4"}},{"id":4298187,"issuer":{"id":166664,"kind":"organization","name":"AveXis, Inc.","symbol":"AVXS"},"owners":[{"id":117320,"kind":"person","name":"Siffert Joao MD","position":1,"cik":"0001534986","reported_name":"Siffert Joao MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-01T19:40:20.000Z","date":"2017-05-30","kind":"grant","acquired":true,"shares":2454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable (i) in twelve equal monthly installments beginning on June 30, 2017, or (ii) on the date of the Issuer's next annual stockholder meeting, whichever comes first, in each case subject to the Reporting Person's Continuous Service (as that term is defined in the Issuer's 2016 Equity Incentive Plan (the \"Plan\")) through each such date."}],"balance_after":2454,"derivative":{"exercise_price":69.25,"expiration_date":"2027-05-30","underlying":"Common Stock","underlying_shares":2454},"source":{"system":"sec-edgar","filing":"0001209191-17-036959","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652923/000120919117036959/doc4.xml","form_type":"4"}}]}